← Back to Clinical Trials
Recruiting NCT07211698

NCT07211698 Ethnic Minorities Experiences of Healthcare Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07211698
Status Recruiting
Phase
Sponsor University of Nottingham
Condition Healthcare Inequities
Study Type OBSERVATIONAL
Enrollment 45 participants
Start Date 2025-10-20
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Qualitative study - Phase 1Qualitative study - Phase 2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 45 participants in total. It began in 2025-10-20 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As ethnic diversity in Britain continues to grow, so do the health needs in a society with many different ethnic backgrounds, including the need for personalised healthcare. Studies show that people from ethnic minority groups are at a higher risk of illness and death compared to white people with the same health issues. For example, ethnic minority individuals have strokes five years earlier than white people and are at greater risk of serious problems, including an increased risk of falling. These differences are made worse because people from ethnic minority communities are less likely to use or engage with healthcare interventions delivered in the community, which increases health inequalities. Ethnic minorities have a greater susceptibility to falls because they are likely to have underlying health issues, such as high blood pressure and diabetes. We do not have enough evidence on what treatment can stop these falls. Older adults who fall can get hurt and may even die from their falls. Research hasn't found the best ways to prevent falls for ethnic minorities, because often, they are underrepresented in the study. The NHS wants to transform care delivery by providing more care in the community rather than in hospitals, by using more digital tools instead of paper methods and focusing more on keeping people healthy rather than just treating sickness. This means healthcare services need to be designed to meet the specific needs of different ethnic groups when they are provided at home or in community centres. This qualitative study is classified into two phases. The purpose of Phase 1 of the study is to understand how people from ethnic minority backgrounds feel about accessing healthcare delivered to them at home or in community centres, with the view to identifying how to help them participate in these services. Semi-structured interviews, focus groups or informal conversations will be conducted with adults from Asian, Black African, Black Caribbean, or Mixed ethnic backgrounds. The study aims to find out what changes can be made to better meet their needs. Phase 1 will explore broad areas of health due to health inequalities in diagnosis and treatment outcomes for the ethnic minority population. This will help understand the relevant factors to consider when delivering interventions. Phase 2 of the study will focus on falls prevention intervention due to the greater susceptibility to falls among ethnic minorities. A range of people deliver falls prevention in the community, for example, exercise instructors, personal trainers, support workers, nurses, AHPs, falls leads, community groups coordinators, etc. A semi-structured interview will be conducted with people delivering falls prevention interventions in the community to explore their experiences of providing tailored treatment to ethnic minorities.

Eligibility Criteria

Phase 1: Inclusion Criteria: * Ethnic minority individuals * Adults aged 18 and over * Never accessed or accessed or used or declined health intervention * Able to provide informed consent * Lives in their own home or living with family/ friend or supported living facilities * Lives in the United Kingdom at the time of study participation Exclusion Criteria: * Patients in hospital admissions * Adults living in care homes Phase 2: Inclusion criteria: * Individuals delivering falls prevention interventions in the community, for example, exercise instructors, personal trainers, support workers, nurses, AHPs, falls leads, community groups coordinators, etc. * From any ethnic background * Adults aged 18 and over * Able to provide informed consent Exclusion criteria: * Provides falls prevention intervention only to inpatients, or in hospital settings, or in care homes * Lives outside of the United Kingdom at the time of study participation

Contact & Investigator

Central Contact

Joy O Watterson, MSc

✉ mzxja3@nottingham.ac.uk

📞 +447812277091

Principal Investigator

Katie Robinson, PhD

PRINCIPAL INVESTIGATOR

School of Medicine, University of Nottingham

Frequently Asked Questions

Who can join the NCT07211698 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthcare Inequities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07211698 currently recruiting?

Yes, NCT07211698 is actively recruiting participants. Contact the research team at mzxja3@nottingham.ac.uk for enrollment information.

Where is the NCT07211698 trial being conducted?

This trial is being conducted at Nottingham, United Kingdom.

Who is sponsoring the NCT07211698 clinical trial?

NCT07211698 is sponsored by University of Nottingham. The principal investigator is Katie Robinson, PhD at School of Medicine, University of Nottingham. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology